July 20, 2017

Cellaviv

Health and Wellness Project

cellaviv-logo

Frank Magliochetti of Parcae Capital is currently working with Cellaviv. This an exciting and unique health and wellness company focused on marketing nutraceuticals that contain the science of stem cell nutrition.

The company has strong  leadership and a long term plan for the businesses continued growth and success.

Here is information aggregated and sourced from the official website.  Please visit the link provided for more detailed information.
https://www.cellaviv.com/index.asp

About Cellaviv

In 2000, Dr. John Capello was stricken with Parkinson Disease symptoms and was forced to retire from the active practice of medicine. This facilitated a search that led him in 2005 to uncover scientific data regarding the ability of certain botanicals to increase adult stem cells in the body’s circulation. Many hours of research were invested by Dr. Cappello to validate the reality of this phenomenon as it related to adult stem cells and the body’s own way to renew itself. Fortunately, Dr. Cappello discovered a way to improve upon what was then available and made it part of his personal daily regimen. Within several months, not only did the Parkinson Disease symptoms begin to disappear but he also experienced improved joint functions. Through his personal experience, Dr. Capello developed a line of patented and patent pending nutraceuticals that contain the science of stem cell nutrition. The products were made available through a direct sales channel that established a large number of loyal customers who were sold on the health benefits.

Cellaviv Opportunity from Emergent Health on Vimeo.

Cellaviv Opportunity

Celebrating Life by providing individuals with the opportunity for enhanced Health, Wellness and Wealth.

If you are looking and are open minded to improved health, wellness and wealth, Cellaviv is delivering the following:

•    Timing – Be one of the first few hundred brand partners in your state.
•    Stock Options – As a publicly traded company (EMGE), Cellaviv leaders can be shareholders and owners.
•    Compensation – Weekly and Monthly bonus incentives fueling an ambitious and lucrative compensation plan.
•    Systems – Mobile and automated systems with unique Wellness Card giveaway program to build your business.
•    Leadership – Executive leaders and advisers with proven track records and a long term plan for the company.
•    International Expansion – Heading south of the border in 2015 and 2016.

EHC

 The Science – Cellaviv

In 2012, the Nobel Committee announced the selection of stem cell researchers John Gurdon of Great Britain and Shinya Yamanaka of Japan for the 2012 Prize in physiology and medicine. In experiments spanning over a 50-year period, Gurdon and Yamanaka “have revolutionized our understanding of how stem cells and organisms develop,” the Committee said in its announcement.
Traditional nutritional supplementation focuses on feeding good ingredients to cells that are dying. Cellaviv was founded with patented and patent pending Stem Cell Nutrition formulations which focus on supporting the release of stem cells so they can do what they are best at – giving you what you need when you need it.

 In fact, stem cell nutrition has been proven to increase the level of adult stem cells in the body by 25 to 30%. 2013 was actually hailed “The Year of the Stem Cell”.Building off this foundation, Cellaviv is leading a campaign to address growing health concerns by promoting health, wellness and wealth to individuals worldwide and take advantage of the following statistics:

•    87% of U.S. consumers take some form of dietary supplements.
•    80% of adults consume some type of energy beverage each day.
•    67% of Americans are concerned about losing weight.
•    38% have a sleep or wakefulness disorder.
•    Heart disease (which includes Heart Disease, Stroke and other Cardiovascular Diseases) is the No. 1 cause of death in the United States, killing nearly 800,000 people per year.
•    The broader Global Health and Wellness market is expected to be a trillion dollar industry by the end of 2017.
•    Health trends are continuing to move from reactive to proactive and from treatment to prevention

Frank Magliochetti is managing partner of Parcae Capital Corporation.

Med-Final

 

Cellavi

Health and Wellness Project

cellaviv-logo

Frank Magliochetti of Parcae Capital is currently working with Cellaviv.
Cellaviv is a unique health and wellness company focused on marketing nutraceuticals that contain the science of stem cell nutrition.

The company has strong leadership  and a long term plan for the businesses continued growth and success.

Here is information aggregated and sourced from the official website.

Please visit the link provided for more detailed information.
https://www.cellaviv.com/index.asp

About Cellaviv

In 2000, Dr. John Capello was stricken with Parkinson Disease symptoms and was forced to retire from the active practice of medicine. This facilitated a search that led him in 2005 to uncover scientific data regarding the ability of certain botanicals to increase adult stem cells in the body’s circulation. Many hours of research were invested by Dr. Cappello to validate the reality of this phenomenon as it related to adult stem cells and the body’s own way to renew itself. Fortunately, Dr. Cappello discovered a way to improve upon what was then available and made it part of his personal daily regimen. Within several months, not only did the Parkinson Disease symptoms begin to disappear but he also experienced improved joint functions. Through his personal experience, Dr. Capello developed a line of patented and patent pending nutraceuticals that contain the science of stem cell nutrition. The products were made available through a direct sales channel that established a large number of loyal customers who were sold on the health benefits.

Cellaviv Opportunity from Emergent Health on Vimeo.

Cellaviv Opportunity

Celebrating Life by providing individuals with the opportunity for enhanced Health, Wellness and Wealth.

If you are looking and are open minded to improved health, wellness and wealth, Cellaviv is delivering the following:

•    Timing – Be one of the first few hundred brand partners in your state.
•    Stock Options – As a publicly traded company (EMGE), Cellaviv leaders can be shareholders and owners.
•    Compensation – Weekly and Monthly bonus incentives fueling an ambitious and lucrative compensation plan.
•    Systems – Mobile and automated systems with unique Wellness Card giveaway program to build your business.
•    Leadership – Executive leaders and advisers with proven track records and a long term plan for the company.
•    International Expansion – Heading south of the border in 2015 and 2016.

EHC

 The Science – Cellaviv

In 2012, the Nobel Committee announced the selection of stem cell researchers John Gurdon of Great Britain and Shinya Yamanaka of Japan for the 2012 Prize in physiology and medicine. In experiments spanning over a 50-year period, Gurdon and Yamanaka “have revolutionized our understanding of how stem cells and organisms develop,” the Committee said in its announcement.
Traditional nutritional supplementation focuses on feeding good ingredients to cells that are dying. Cellaviv was founded with patented and patent pending Stem Cell Nutrition formulations which focus on supporting the release of stem cells so they can do what they are best at – giving you what you need when you need it.

 In fact, stem cell nutrition has been proven to increase the level of adult stem cells in the body by 25 to 30%. 2013 was actually hailed “The Year of the Stem Cell”.Building off this foundation, Cellaviv is leading a campaign to address growing health concerns by promoting health, wellness and wealth to individuals worldwide and take advantage of the following statistics:

•    87% of U.S. consumers take some form of dietary supplements.
•    80% of adults consume some type of energy beverage each day.
•    67% of Americans are concerned about losing weight.
•    38% have a sleep or wakefulness disorder.
•    Heart disease (which includes Heart Disease, Stroke and other Cardiovascular Diseases) is the No. 1 cause of death in the United States, killing nearly 800,000 people per year.
•    The broader Global Health and Wellness market is expected to be a trillion dollar industry by the end of 2017.
•    Health trends are continuing to move from reactive to proactive and from treatment to prevention

Frank Magliochetti is managing partner of Parcae Capital Corporation.

Med-Final

 

Projects

Frank Magliochetti Current Works-

ParceaCapital_FrankMagliochetti

Parcae Capital offers personalized investment banking services for emerging growth companies. We specialize in finding companies which have leading edge technology, services or intellectual property in the healthcare, media and alternative energy space. We assist both public and private companies in preparing to raise private and public capital for all phases of growth. Parcae Capital also offers comprehensive assistance in mergers, acquisitions and related services. Our work out group specializes in business restructuring and recapitalization.

Absolute Day Trader Picks

Day Trader Picks

Is a site sponsored and driven by content supplied by North Andover Businessman Frank Magliochetti and Parcae Capital Corporation.  Absolute Day Trader will highlight emerging growth companies and picks made by Frank Magliochetti and his team of professionals.

If you have a company interested in having our team review for our Absolute Day Trading Pick please contact us by clicking here.

Murphy's Pub Salem, MA

 

About

Frank Magliochetti-

North Andover businessman Frank Magliochetti is a sophisticated savvy strategy and finance consultant.

Frank is managing  partner of Parcae Capital and profiles trending businesses for Absolute Day Trader Stock Picks

ParceaCapital_FrankMagliochetti

 

Background – History

was born September 13, 1957 in Malden, Massachusetts. He attended Malden Catholic High School and was a four letter athlete for the school. After high-school he obtained a B.S. in Pharmacy from Northeastern University and played Baseball and football. He stayed at Northeastern and entered the Masters of Toxicology program. Where he worked on the effects of Valium and its metabolism while taking Tagamet for the condition of anxiety induced ulcers. He later received his MBA from The Sawyer School of Business at Suffolk University specializing in corporate finance, completed the Advanced Management Program at Harvard Business School and the General Management Program at Stanford Business School. Frank started a chain of independent pharmacies shortly out of school and eventually sold it. He worked in various positions throughout the American Hospital Supply and later the Baxter International organization prior to leaving he was part of the senior management team for the Neuro-surgical business unit.

Frank spent a period of time as an investment banker prior to becoming the President of Kontron Instruments a maker of a class 3 medical device; an Intra-Aortic Balloon and console. He worked with the Food & Drug administration in developing internal policies and practices which would eventually lead to the removing of the consent decree which was placed on the company for poor manufacturing practices prior to his involvement. He returned the company to profitability after a long period of losses. Kontron was eventually sold to a prominent medical device company. As Senior Vice President of North America for Haemonetics Corporation, Frank managed the day to day activities for the North America business activities. During his tenure sales and profits grew double digits for 13 consecutive quarters and the stock of the Company doubled and forward split and grew 40% before he left to run Sandoz Pharma North American Operations. Sandoz eventually merged with Ciba becoming one of the largest Pharma companies in the world, Novartis.

Frank then went on to create one of the largest infusion therapy and medicare nursing companies in the world, employing more than 40,000 employees. Over a three year period he saw his stock appreciate 10 fold. He then created several orthopedic product and services entities. One of which, Orthorehab, was sold for 52 times its original investment just 30 months after starting it for 52 million dollars.

He currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

Frank now is managing partner of North Andover company Parcae Capital where he spends his time restructuring companies and investing in new companies.

Parcae Capital Corp

Client satisfaction is Parcae Capital’s  top priority.

ParceaCapitalManhattenSkyline_Frank Magliochetti

Parcae Capital success depends on exceeding expectations.

Frank Magliochetti is a founder of Parcae Capital.

Parcae Capital offers personalized investment banking services for emerging growth companies. They specialize in finding companies which have leading edge technology, services or intellectual property in the healthcare, media and alternative energy space. Parcae Capital assist both public and private companies in preparing to raise private and public capital for all phases of growth. Parcae Capital also offers comprehensive assistance in mergers, acquisitions and related services. They have a  work out group led by Frank Magliochetti which specializes in business restructuring and recapitalization.

Parcae Capital offers comprehensive assistance in mergers, acquisitions and related services.
They provide assistance in initiating, structuring, valuing, negotiating, financing and consummating mergers and acquisitions. Parcae Capital is a  firm  involved in the purchasing, selling of privately owned companies, divesture of corporate subsidiaries and divisions, the formation of joint ventures and strategic alliances.

Parcae Capital offers personalized investment banking services for emerging growth companies. In keeping with the firm’s philosophy, they seek to develop long term relationships with their clients. Parcae Capital’s key focus is in private placements, mergers and acquisitions, corporate restructuring and reverse merger advisory services.

Parcae Capital assists both public and private companies in raising private capital for all phases of growth. 
They have a long standing relationships with high net worth individuals and financial institutions provide valuable resources in consummating private placement transactions in a timely manner.
Parcae Capital specializes in finding companies which have leading edge technology, services or intellectual property in the healthcare and bio-fuel sectors.
They then add value to these companies by helping with various forms of financing, restructuring and merger advisory services of the highest quality.  Parcae Capital professionals have the industry experience, knowledge and relationships needed to successfully advise and guide growth companies.

Parcae Capital advises in business restructuring and recapitalization.
The interdisciplinary experience of their professionals allows them to offer creative analysis and implementation services in a variety of assets, sales, corporate divestitures and capital and balance sheet restructuring. Services include identifying and analyzing restructuring opportunities, negotiating terms and conditions, implementing asset purchase and sale agreements.

Parcae Capital Corporation was founded by Frank Magliochetti.